YPrime

Interactive Response Technology (IRT) plays an increasingly significant role in addressing the complex challenges of drug management and distribution for decentralized and hybrid clinical trials. Register for this webinar to learn more about how this technology can be used more effectively to enable patient-centric clinical trials.

http://www.appliedclinicaltrialsonline.com/act_w/IRT_landscape

Patient-centric clinical trials such as decentralized or hybrid clinical trials can create complex challenges for drug management and distribution. Interactive Response Technology (IRT) plays an increasingly significant role in delivering an efficient and streamlined experience for patients, sites, and sponsors. Understanding how this technology can be used more effectively to deliver a better experience while minimizing risks to clinical trials will be one key to the successful adoption of decentralized and hybrid clinical trials.





By the end of this webinar, attendees will be able to:


List some of the major challenges the DCT or hybrid model can create for drug management and distribution

Discuss how IRT can be used effectively in DCTs

Examine how the industry can work collaboratively to improve how this technology enables DCTs and hybrid trials

Directors and VPs of clinical development, clinical research, R&D, IRT, IT

Managers of clinical development, clinical research, R&D, IRT, IT

Jon Paras is Vice President of Strategic Solutions for YPrime. An industry-recognized IRT subject matter expert, Jon has more than twenty years of experience in IRT software testing, project management, business analysis/software design, business process efficiency, and clinical supply chain / IRT synergy. He collaborates with biopharmaceutical companies on the appropriate application of IRT design based on clinical protocol and sponsor business process.


Webcasts

Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET

The Importance of IRT in the Decentralized Clinical Trial Landscape

Articles

Strategies and Technologies that Empower DCTs

Tech Solutions for Decentralized Clinical Trials

Podcasts

Overcoming Technology Challenges in Decentralized Clinical Trials 

http://www.appliedclinicaltrialsonline.com/act_w/eClinical_Tech

Industries that focus on providing applications to the consumer market have long been masters at engaging, incentivizing, and motivating their customers. Companies such as Peloton, Apple, Noom, Duolingo, and FitBit leverage behavioral science principles to influence consumer decision-making and keep them engaged with their products. These companies have a deep understanding of what makes their customers tick, what their expectations are, what their preferred experience is. The eClinical technology industry, on the other hand, is in its infancy when it comes to using these behavioral techniques while designing applications for patients involved in clinical trials. This webinar will address:

Lessons the eClinical space can learn from consumer engagement

How to “scale” empathy using eClinical applications

How consumer engagement methods can be used in eClinical applications to engage, incentivize, and motivate patients in clinical trials

By the end of this webinar, attendees will be able to:

List examples of behavioral science approaches that influence consumers and how industries have successfully used these approaches

Describe why it’s important to apply this same approach to eClinical technologies and applications

List some of the ways eClinical technologies/applications can be used to engage, incentivize, and motivate patients in clinical trials

Anyone who is responsible for planning or developing applications for patients involved in clinical trials

Clinical trial strategists interested in how behavioral science approaches can be used successfully in the research setting

Ian Greenfield helped transform Oregon’s healthcare delivery system while serving in Governor John A. Kitzhaber, MD’s administration. He has held leadership positions in numerous companies and non-profit organizations, including the world’s leading death with dignity advocacy group, Compassion & Choices. His marketing work has earned both an International Association of Business Communicators’ Bronze Beacon Award and a Public Relations Society of America Award of Excellence.

Tuesday, May 3, 2022 at 11am EDT | 7am PDT | 3pm BST | 4pm CEST

What can the eClinical technology industry learn from consumer-focused technology companies? They can learn effective approaches that help engage, incentivize, and motivate patients in clinical trials, to improve recruitment and decrease attrition. 

Applying a Consumer Approach to eClinical Technology

•	Regulatory has begun to investigate new methods and technologies for the clinical trial process.
•	Clinical trials will have more decentralized components going forward.
•	The key is matching a protocol and patient with the new components of DCT.

Videos

YPrime President, Mark Maietta, discusses the future of decentralized clinical trials following Covid-19. Adaptations will need to be made as DCT is here to stay.